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Here we provide raw and processed data and methods behind mTOR
siRNA loaded DNA nanotubes (siRNA-DNA-NTs) in the growth of
pulmonary arterial smooth muscle cells (PASMCs) under both
normoxic and hypoxic condition, and also related to (You et al.,
Biomaterials, 2015, 67:137–150, [1]). The MTT analysis, Semi-quan-
titative RT-PCR data presented here were used to probe cytotoxicity of
mTOR siRNA-DNA-NT complex in its TAE-Mg2þ buffer. siRNA-DNA-
NTs have a lower cytotoxicity and higher transfection efﬁciency and
can, based on inhibition of mTOR expression, decrease PASMCs growth
both hypoxic and normal condition.
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Type of data Image, graph, ﬁgure
How data was acquired MTT assay, confocal laser scanning microscopy, ﬂuorescence-activated cell sorting
Data format Raw, analyzed
Experimental factors Effect of nanoparticles on the cell growth in vitro
Experimental features Characterization and action of siRNA loaded DNA nanotubes
Data source location Chongqing, China
Data accessibility The data presented in this article and is related to [1]Value of the data The data can be referenced by investigating the action of the transfection reagents for self-
assembly DNA nanoparticles' transfection to mammalian cells. These data provides a thorough understanding of the basic cytotoxicity of self-assembly DNA
nanoparticles in PASMCs. The data can provide comprehensive analysis of the regulation of self-assembly siRNA-loaded
nanotubes on PASMC growth.1. Data, experimental design, materials and methods
1.1. Analysis of the cytotoxicity of mTOR siRNA loaded DNA nanotubes by IC50
For the half-maximal inhibitory concentration (IC50) test, 4103 of PASMCs (per well) were
cultured in 96-well plates for 24 h, and the cells were then treated with the pure nanotubes or the
1TAE-Mg2þ buffer at various concentration for another 48 h. The cytotoxicity of the pure nanotubes
and the TAE buffer was then determined by IC50 assay.1.2. Optimizing ratio of X-tremeGENE siRNA transfection reagents and siRNA-DNA-NTs in the cells
determined by ﬂow cytometry
Based on the procedure of X-tremeGENE siRNA Transfection Reagents, ﬁrst, the complex of
transfection reagent and siRNA-DNA-NTs was prepared and transfected into the cells in a 24-well
plate. The used ratios of the reagent (μl) to the NTs (μg) were 10:2, 2.5:0.5, 1:0.2, respectively. Then
optimizing ratio of the transfection reagent to siRNA-DNA-NTs in PASMCs was tested by ﬂow
cytometry. During this process, the transfection reagent was kept in a ratio of 0.5–8 to the siRNA-NTs
by varying the siRNA-NTs concentration. Samples of at least 10,000 cells were analyzed in duplicate
using a FACS Calibur ﬂow cytometer (BD Biosciences, USA)1.3. Cell viability and cell growth assay by MTT test
PASMCs were cultured in 96-well plates (5103 cells per well) for 24 h, and the cells were then
treated with 50 nM mTOR siRNA loaded DNA nanotubes at various doses for 0, 12, 24, or 48 h,
respectively. The cell viability and growth was then determined by MTT assay as the following
instruction. After the treatment, 10 μL of MTT Reagent was added to each well. Then the plate was
returned to cell culture incubator for 4 h. When the purple precipitate was clearly visible under the
microscope, 100 μL of Detergent Reagent was added to all wells. The plate with cover was in the dark
for 3 h and then the absorbance in each well was measured at 570 nm in a microtiter plate reader.
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At a predetermined time after transfection, total RNAwas isolated from transfected PASMCs. The
transfected cells were prepared for mRNA extraction using the Trizol reagent (Invitrogen, USA)
according to the manufacturer's recommendations. Semi-quantitative RT-PCR analysis of mTOR
mRNA expression in the transfected cells was then performed as previously described [2,3]. All
samples were run in triplicate, and the levels of mRNA in each sample were normalized to those of
β-actin. The mTOR forward primer was 50-CGCAGGGAAGGTGATGAGGAAT-30, and the reverse
primer was 50-GCTAAGGAGCAGCCAGGGAGAT-30. The internal-control β-actin forward primer was
50-TCAGGTCATCACTATCGGCAAT-30, and the reverse primer was 50-AAAGAAAGGGTGTAAAACGCA-30.
The PCR products were separated by electrophoresis on a 1.0% agarose gel containing 0.5% ethidium
bromide.2. Data
2.1. Cytotoxicity of the DNA-NTs for PASMCs
In Fig. 1, the cytotoxicity of DNA nanotube solution and the solvent (1TAE-Mg2þ) at various
concentrations in PASMCs is represented. The IC50 of DNA nanotubes was found to be 1071.4 nM
(Fig. 1A). While the IC50 of the 1 TAE-Mg2þ buffer used for the DNA-NTs was approximatelyFig. 1. The cytotoxicity of DNA nanotube solution and the solvent (1 TAE-Mg2þ) at various concentrations in PASMCs. The
data represent the mean7S.E. (n¼5).
Fig. 2. Optimum ratio of the transfection reagents to mTOR siRNACy3-loaded DNA-NTs in PASMCs. The data represent the
mean7S.E. of three separate experiments. *po0.05 versus the 1:0 ratio group and ̂po0.05 versus the 1:0.25 ratio group.
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Mg2þ buffer, was much lower to 141 nM by the pure nanomaterials (Fig. 1B).2.2. Optimization of transfection reagents for mTOR siRNA-DNA-NTs
Fig. 2 exhibits that optimization ratio of transfection reagents to mTOR siRNACy3-loaded DNA-NTs
in PASMCs. Fig. 2A shows the typical ﬂuorescence images of the transfection reagent-dependent
cellular uptake of the mTOR siRNA-DNA-NTs, as obtained by confocal microscopy. Here, 1:0, 1:0.25,
1:0.5, 1:1 and 1:2 ratios of siRNA (μg) to X-tremeGENE siRNA Transfection Reagent (μL) were used. The
cells were incubated for 24 h with DNA-NTs containing mTOR siRNACy3 at 50 nM. The merged images
show whole cells with DAPI-stained nuclei. Fig. 2B shows ﬂow cytometry analysis of the transfection
efﬁciency of PASMCs after incubation with various ratios of siRNA-loaded nanotubes (μg) to
transfection reagent (μL) for 24 h. The 1:1 ratio of X-tremeGENE siRNA Transfection Reagent (μL) to
Fig. 3. Cell growth inhibition by mTOR siRNA-loaded nanotubes under normoxic condition. The data represent the mean7S.E.
(n¼4). *po0.05 versus the 0 nM group and ̂po0.05 versus the 25 nM group.
Fig. 4. Effect of mTOR siRNA-DNA-NTs on the growth of PASMCs under hypoxic condition. The cell viability was assessed by
MTT assay. All of the data were normalized to the mean count numbers under normoxia. The data are the mean7S.E. (n¼4).
*po0.05 versus the normal group (0 h), p̂o0.05 versus the group with 24 h of treatment, and po0.05 versus the
corresponding hypoxic group at 24 or 48 h.
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normal ratio (5:1) without the DNA-NTs' assistance.
2.3. Inhibition of mTOR siRNA-NTs on cell growth under normoxic condition
Fig. 3 shows in normal condition, that cell growth inhibition of mTOR siRNA-loaded nanotubes is in
a time- and dose-dependent manner using MTT method. The histogram display that the cells were
treated by mTOR siRNA-loaded nanotubes at doses of 12.5, 25, 50, and 100 nM, respectively, for 0, 12,
24, and 48 h, respectively. By treatment with 50 nM of mTOR siRNA loaded DNA-NTs, the inhibition
rate of cell growth was 2.4%, 11.9%, 27.3%, 34.6%, 46.8% at 12, 24, 36, 48 h, respectively.
2.4. Inhibition of mTOR siRNA-NTs on the cell growth under hypoxic condition
Fig. 4 shows the viability of PASMCs incubated with 50 nM of mTOR siRNA treatment for
predetermined amounts of time (0, 12, 24, 48 h) by the MTT assay. Cells were ﬁrst cultured in 1%
serum for 16 h and were then transfected with 50 nM of mTOR siRNA treatment, followed by exposure
to hypoxia for another 0, 12, 24, or 48 h. Speciﬁcally, the PASMCs were pre-cultured with 3-MA
Fig. 5. Inhibition of mTOR siRNA-DNA-NTs on the mTOR expression in PASMCs. The data represent the mean7S.E. (n¼3). (A)
*po0.05 versus control group and ̂po0.05 versus the siRNA alone group. (B) *po0.05 versus the 0 h group and ̂po0.05 versus
the group incubated for 24 h. (C) *po0.05 versus the 0 nM group and ̂po0.05 versus the 25 nM group.
Z. You et al. / Data in Brief 5 (2015) 28–34 33(5 mM) for 30 min and then transfected with the siRNA-DNA-NTs. MTT assay showed that the rate of
cell growth decreased by 11%, 42%, and 78% compared with correspondent alone hypoxic group at 12,
24, 48 h, respectively.2.5. Inhibition of mTOR siRNA-loaded nanotubes on mTOR expression in PASMCs
Fig. 5 reveals the inhibition of mTOR siRNA-loaded nanotubes on mTOR expression in PASMCs.
First, comparison of the inhibition of mTOR siRNA with or without DNA-NTs in PASMCs is in Fig. 5A.
PASMCs were incubated with 50 nM siRNA alone and siRNA-DNA-NTs for 48 h. Representative bands
show the expression of mTOR mRNA (upper panel) and β-actin (middle panel). The histograms in the
lower panel illustrate the levels of mTOR, which were normalized to the β-actin expression. Second,
mTOR mRNA levels were decreased in a time-dependent manner (Fig. 5B). PASMCs were incubated
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Representative bands show the expression of mTOR mRNA (upper panel) and β-actin (middle panel).
The histograms in the lower panel illustrate the levels of mTOR, which were normalized to the β-actin
expression. Third, mTOR mRNA levels were suppressed in a concentration-dependent manner
(Fig. 5C). PASMCs were incubated with various concentrations of siRNA-DNA-NTs (0, 12.5, 25, 100 mM)
for 48 h. Representative bands show the expression of mTOR mRNA (upper panel) and β-actin (middle
panel). The histograms in the lower panel illustrate the levels of mTOR, which were normalized to the
β-actin expression.Competing interests
The authors declare that they have no competing interestsAuthor contributions
Concept and design, GW, CM; acquisition of data and experiments performance, ZY, HQ, CW, BH, JY;
analysis and interpretation, ZY, HQ, GW; drafting and editing of the manuscript, ZY, HQ, CM, GW. The
manuscript was written through contributions of all authors. All authors have given approval to the
ﬁnal version of the manuscript.Acknowledgments
We thank Prof. Guisheng Qian, Zhong Shi, Renjie Zhou for suggestion, and Zhenghua Wei, Huaping
Chen, Jin Li, Zi Wang, Zhou Long, Qing Zhang for technical assistance. This research was supported by
China Joint Research Fund for Overseas Chinese, Hong Kong and Macao Scholars 81429001 (CM and
GW) and NSFC Grant 81370168 (GW).
References
[1] Z You, H Qian, C Wang, B He, J Yan, C Mao, G. Wang, Regulation of vascular smooth muscle cell autophagy by DNA nanotube-
conjugated mTOR siRNA, Biomaterials 67 (2015) 137–150.
[2] H Chen, X Liu, Y Dou, B He, L Liu, Z Wei, et al., A pH-responsive cyclodextrin-based hybrid nanosystem as a nonviral vector
for gene delivery, Biomaterials 34 (2013) 4159–4172.
[3] MV Pryzhkova, I Aria, Q Cheng, GM Harris, X Zan, M Gharib, et al., Carbon nanotube-based substrates for modulation of
human pluripotent stem cell fate, Biomaterials 35 (2014) 5098–5109.
